GC Biopharma announced on the 21st that it will introduce two advertisements for its anti-inflammatory pain reliever 'Taksen.' The campaign will focus on promoting Taksen as the top-selling treatment for headaches, menstrual pain, and muscle pain. It will utilize wordplay, such as 'migraine, severe headache, recurrent headache, Taksen for headaches.' GC Biopharma noted, 'Anti-inflammatory pain relievers are essential over-the-counter medications for all generations,' adding that the advertisements are designed to appeal to a broad audience. The ads will be available on YouTube, Netflix, and social media.
GemVax announced on the 21st that its treatment for progressive muscular dystrophy, 'GV1001,' has received approval for therapeutic use from the Ministry of Food and Drug Safety. Progressive muscular dystrophy is a disease where nerve cells controlling eye movements degenerate, leading to cognitive impairment, balance loss, and muscle rigidity. The ministry has authorized the use of clinical trial drugs for more than two patients with progressive muscular dystrophy when there are no other treatment options or when the condition threatens life.
Dongkook Pharmaceutical announced on the 21st that it recently conducted a national park hiking safety campaign at the entrance of hiking trails in Seoul. Staff from Dongkook Pharmaceutical and the Korea National Park Service distributed maps to hikers, which contained safety guidelines and the locations of first aid kits. Since 2009, Dongkook Pharmaceutical has held a hiking safety campaign every spring and autumn after signing an agreement with the Korea National Park Service to promote a safe mountain culture.
Seoul National University Hospital announced on the 21st that Professor Lee Hyuk-jun of the Department of Gastrointestinal Surgery has been elected as the next president of the International Gastric Cancer Association. His term will begin in 2029 and last for two years. Established in 1995, the International Gastric Cancer Association is a scholarly organization focused on gastric cancer. Medical professionals from Korea, Japan, China, Europe, and the United States discuss the advancement of gastric cancer prevention and treatment. Professor Lee, an expert in gastric cancer, laparoscopic surgery, and metabolic surgery, serves as the director of the Seoul National University Hospital Gastric Cancer Center.
The Ministry of Food and Drug Safety announced on the 21st that manufacturers of tick repellents can release products by simply notifying the ministry, provided they manufacture according to standard criteria, without needing approval. The ministry has proposed an administrative notice to revise the standard manufacturing criteria for non-drug products accordingly. The ministry expects that this will reduce the burden of new product development for tick repellent companies and lead to a wider variety of products on the market.